Barclays’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.93M Buy
197,579
+5,581
+3% +$111K ﹤0.01% 1788
2025
Q1
$3.24M Buy
191,998
+11,601
+6% +$196K ﹤0.01% 1716
2024
Q4
$3.33M Buy
180,397
+5,542
+3% +$102K ﹤0.01% 1880
2024
Q3
$3.8M Buy
174,855
+32,250
+23% +$701K ﹤0.01% 1712
2024
Q2
$2.8M Sell
142,605
-8,536
-6% -$167K ﹤0.01% 1481
2024
Q1
$3.28M Buy
151,141
+101,607
+205% +$2.21M ﹤0.01% 1603
2023
Q4
$1.43M Buy
49,534
+35,904
+263% +$1.04M ﹤0.01% 2373
2023
Q3
$365K Buy
13,630
+910
+7% +$24.4K ﹤0.01% 2717
2023
Q2
$472K Sell
12,720
-907
-7% -$33.7K ﹤0.01% 2632
2023
Q1
$426K Buy
13,627
+3,765
+38% +$118K ﹤0.01% 2744
2022
Q4
$293K Buy
9,862
+4,552
+86% +$135K ﹤0.01% 2901
2022
Q3
$203K Sell
5,310
-5,475
-51% -$209K ﹤0.01% 3079
2022
Q2
$589K Sell
10,785
-9,253
-46% -$505K ﹤0.01% 2464
2022
Q1
$1.25M Sell
20,038
-8,642
-30% -$539K ﹤0.01% 2135
2021
Q4
$2.89M Buy
28,680
+8,393
+41% +$844K ﹤0.01% 1586
2021
Q3
$1.83M Buy
20,287
+7,924
+64% +$713K ﹤0.01% 1928
2021
Q2
$1.14M Sell
12,363
-6,216
-33% -$573K ﹤0.01% 2038
2021
Q1
$1.79M Buy
18,579
+3,910
+27% +$378K ﹤0.01% 1948
2020
Q4
$764K Buy
14,669
+1,204
+9% +$62.7K ﹤0.01% 2119
2020
Q3
$540K Buy
13,465
+8,116
+152% +$325K ﹤0.01% 2266
2020
Q2
$85K Buy
+5,349
New +$85K ﹤0.01% 3184
2017
Q3
Sell
-4,800
Closed -$31K 4046
2017
Q2
$31K Buy
4,800
+3,778
+370% +$24.4K ﹤0.01% 3157
2017
Q1
$11K Buy
1,022
+920
+902% +$9.9K ﹤0.01% 3509
2016
Q4
$1K Buy
+102
New +$1K ﹤0.01% 3693